Importantly, reduced TRKB protein is observed in post-mortem samples of Alzheimer’s disease patients [6,15,16], as well as, Parkinson’s disease [17], demonstrating the importance of TRKB to neuronal survival. This evidence concerns the gene NTRK2 and early-onset autosomal dominant Alzheimer disease.